alogliptin
Showing 26 - 39 of 39
Diabetes Trial in Worldwide (Alogliptin, Glipizide)
Diabetes, Type 2 Trial in China, Hong Kong, Taiwan (Alogliptin, Placebo to alogliptin, Metformin)
Completed
- Diabetes Mellitus, Type 2
- Alogliptin
- +3 more
-
Beijing, Beijing, China
- +20 more
Feb 17, 2013
Type 2 Diabetes Trial in Worldwide (Alogliptin, Alogliptin , Pioglitazone)
Completed
- Type 2 Diabetes Mellitus
- Alogliptin
- +3 more
-
Birmingham, Alabama
- +89 more
Feb 19, 2013
Diabetes, Type 2 Trial in Worldwide (Alogliptin, Metformin, Alogliptin Placebo)
Completed
- Diabetes Mellitus, Type 2
- Alogliptin
- +3 more
-
Dothan, Alabama
- +200 more
Feb 17, 2013
Diabetes Trial in Worldwide (Alogliptin, Pioglitazone, Placebo)
Completed
- Diabetes Mellitus
- Alogliptin
- +2 more
-
Columbiana, Alabama
- +160 more
Feb 19, 2013
Cancer in Diabetic Patients
Unknown status
- Type 2 Diabetes Mellitus
- Sitagliptin
- +2 more
-
Kurume, Fukuoka, Japan
- +1 more
Oct 17, 2012
Diabetes, Type 2 Trial in Okayama (Alogliptin, Voglibose, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Alogliptin
- +2 more
-
Okayama, Japan(unnamed)
Feb 1, 2012
Type 2 Diabetes Trial (Alogliptin, Voglibose)
Diabetes, Type 2 Trial in Nagoya, Okazaki, Yokkaichi (Alogliptin, Metformin 750 mg)
Unknown status
- Diabetes Mellitus, Type 2
- Alogliptin
- Metformin 750 mg
-
Nagoya, Aichi, Japan
- +3 more
Feb 23, 2011